Description
CAS 3918-84-1
Cardiovascular disease was long viewed mainly as a mechanical problem of the heart and blood vessels, but modern research shows that aging and cellular changes play a major role in heart decline. Scientists now understand that heart cells can renew slightly and that heart aging involves changes in gene activity, energy production, inflammation, and gradual tissue scarring. In this context, researchers explored the idea of using small natural peptides to “reset” aged cells by restoring healthier gene patterns. This approach was developed mainly in Soviet and Eastern European aging research and led to the discovery of Cardiogen, a short peptide taken from heart tissue. Cardiogen is believed to send regulatory signals that support the heart’s natural repair systems without causing harmful growth or abnormal heart rhythms. It is seen as a way to help the heart age more healthily by working at the level of gene regulation rather than simply treating symptoms (Lakatta & Levy, 2003; Khavinson et al., 2003).
References
Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: A “set up” for vascular disease. Circulation.
Khavinson, V. K., et al. (2003). Peptide bioregulators and geroprotection: A new approach to slowing aging. Advances in Gerontology.
